Literature DB >> 17610585

Behavioural characteristics and gene expression in the hyperactive wiggling (Wig) rat.

Yoshinori Masuo1, Masami Ishido, Masatoshi Morita, Hirofumi Sawa, Kazuo Nagashima, Etsuo Niki.   

Abstract

Recently, congenic wiggling (Wig) rats were described as a good model for attention-deficit hyperactivity disorder; 12- to 14-week-old animals demonstrated hyperactivity, impulsive behaviour and an impaired working memory. Here, we show that 4- to 5-week-old Wig rats displayed significantly greater spontaneous motor activity than control rats during a period of darkness. Subcutaneous injection of 4 mg/kg methamphetamine exacerbated hyperactivity, the reverse of its effect in rats with neonatally induced 6-hydroxydopamine lesions. Immunohistochemistry showed low levels of tyrosine hydroxylase in the ventral midbrain, similar to 6-hydroxydopamine-treated rats. In cDNA macroarrays, 4-week-old Wig rats showed increased expression of the adenosine A2a receptor in the dorsal striatum, macrophage migration inhibitory factor in the frontal cortex, ventral striatum and midbrain, and calbindin 2 in the dorsal and ventral midbrain. Expression of the gamma-aminobutyric acid (GABA) transporter and sterol carrier protein 2 genes was reduced in all regions. Dopamine transporter gene expression was increased in the dorsal midbrain but decreased in the ventral midbrain, a pattern distinct from that induced by 6-hydroxydopamine. Although abnormal development of dopaminergic neurons may underlie motor hyperactivity, other mechanisms may control responsiveness to methamphetamine. Wig rats may provide a model of attention-deficit hyperactivity disorder in which treatment with psychostimulants accelerate the hyperactivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610585     DOI: 10.1111/j.1460-9568.2007.05613.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  6 in total

Review 1.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

2.  Sterol carrier protein-2: binding protein for endocannabinoids.

Authors:  Elizabeth Sabens Liedhegner; Caleb D Vogt; Daniel S Sem; Christopher W Cunningham; Cecilia J Hillard
Journal:  Mol Neurobiol       Date:  2014-02-09       Impact factor: 5.590

Review 3.  Smell and Stress Response in the Brain: Review of the Connection between Chemistry and Neuropharmacology.

Authors:  Yoshinori Masuo; Tadaaki Satou; Hiroaki Takemoto; Kazuo Koike
Journal:  Molecules       Date:  2021-04-28       Impact factor: 4.411

4.  Effects of atomoxetine on hyper-locomotive activity of the prenatally valproate-exposed rat offspring.

Authors:  Chang Soon Choi; Minha Hong; Ki Chan Kim; Ji-Woon Kim; Sung Min Yang; Hana Seung; Mee Jung Ko; Dong-Hee Choi; Jueng Soo You; Chan Young Shin; Geon Ho Bahn
Journal:  Biomol Ther (Seoul)       Date:  2014-09-30       Impact factor: 4.634

Review 5.  Allosteric Interactions between Adenosine A2A and Dopamine D2 Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging.

Authors:  Kavya Prasad; Erik F J de Vries; Philip H Elsinga; Rudi A J O Dierckx; Aren van Waarde
Journal:  Int J Mol Sci       Date:  2021-02-09       Impact factor: 5.923

Review 6.  Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development.

Authors:  Stuart P McCluskey; Christophe Plisson; Eugenii A Rabiner; Oliver Howes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-21       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.